TN2011000507A1 - Inhibitors of pi3 kinase and / or mtor - Google Patents

Inhibitors of pi3 kinase and / or mtor

Info

Publication number
TN2011000507A1
TN2011000507A1 TNP2011000507A TN2011000507A TN2011000507A1 TN 2011000507 A1 TN2011000507 A1 TN 2011000507A1 TN P2011000507 A TNP2011000507 A TN P2011000507A TN 2011000507 A TN2011000507 A TN 2011000507A TN 2011000507 A1 TN2011000507 A1 TN 2011000507A1
Authority
TN
Tunisia
Prior art keywords
mtor
kinase
inhibitors
compounds
variables
Prior art date
Application number
TNP2011000507A
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2010/032593 external-priority patent/WO2010126895A1/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of TN2011000507A1 publication Critical patent/TN2011000507A1/en

Links

Abstract

The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds, wherein the variables are as defined herein.
TNP2011000507A 2009-04-28 2011-10-07 Inhibitors of pi3 kinase and / or mtor TN2011000507A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17352009P 2009-04-28 2009-04-28
PCT/US2010/032593 WO2010126895A1 (en) 2009-04-28 2010-04-27 Inhibitors of pi3 kinase and / or mtor

Publications (1)

Publication Number Publication Date
TN2011000507A1 true TN2011000507A1 (en) 2013-05-24

Family

ID=56267930

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2011000507A TN2011000507A1 (en) 2009-04-28 2011-10-07 Inhibitors of pi3 kinase and / or mtor

Country Status (2)

Country Link
TN (1) TN2011000507A1 (en)
UA (1) UA105525C2 (en)

Also Published As

Publication number Publication date
UA105525C2 (en) 2014-05-26

Similar Documents

Publication Publication Date Title
MX2011011335A (en) Inhibitors of pi3 kinase and / or mtor.
MX2011009796A (en) Inhibitors of pi3 kinase.
WO2009155121A3 (en) Inhibitors of pi3 kinase
MX2012000709A (en) Pyrrolopyridine inhibitors of kinases.
MX352672B (en) Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer.
MX2013011591A (en) Methods and compositions for treating neurodegenerative diseases.
MX2013007336A (en) Bi-heteroaryl compounds as vps34 inhibitors.
MX2013011589A (en) Methods and compositions for treating parkinson's disease.
JO2998B1 (en) Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
MX2011012037A (en) Heteroaryl compounds as pikk inhibitors.
HK1131608A1 (en) Pyridinone compounds
MX2015012427A (en) Heteroaryl acid morpholinone compounds as mdm2 inhibitors for the treatment of cancer.
EA201390085A1 (en) COMPOSITIONS OF KINAZ INHIBITORS FOR CANCER TREATMENT
MX2010004260A (en) Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors.
UA99361C2 (en) TRIAZINE COMPOUNDS AS PI3 KINASE AND mTOR INHIBITORS
IN2012DN03085A (en)
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
JO3148B1 (en) Notch pathway signaling inhibitor compound
MX2012004420A (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes.
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
IN2014KN00948A (en)
TN2012000248A1 (en) Novel spiropiperidine compounds
MX2013012588A (en) Kinase inhibitors.
MX2012003007A (en) Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer.